Anti‐nociceptive action of leonurine through TRPA1 and TRPV4 channels modulation
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.70135 ↗At a glance
Journal article in British Journal of Pharmacology, 2025. Written by Matilde Marini and 20 co-authors. Institution: Department of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy. Major MEDLINE topics: TRPV Cation Channels, TRPA1 Cation Channel, Analgesics, Gallic Acid. Cited 6 times so far (Crossref); 73 references. The full text is freely available (open access, CC BY 4.0). Funded by: Next Generation EU. National Recovery and Resilience Plan, Mission 4 Component 2 - Investment 1.4 - National Center for Gene Therapy and Drugs based on RNA Tec…, Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP), A.H. Morice, University of Hull, Hull, UK.
Abstract (original language)
Background and Purpose Leonurine, a pseudoalkaloid derived from Leonotis leonurus , has been traditionally used in herbal medicine to alleviate conditions such as headaches and abdominal discomfort. Its therapeutic effects are often attributed to potential antioxidant properties; however, the precise molecular mechanisms remain poorly understood. Transient Receptor Potential (TRP) channels, particularly TRPA1 and TRPV4 , serve as critical sensors of reactive oxygen species (ROS). Persistent ROS elevation can contribute to pain by activating these channels. Experimental Approach Here, we examined the antinociceptive properties of leonurine and its modulatory effects on TRPA1 and TRPV4 channels after stimulation with selective (allyl isothiocyanate ( AITC ) and GSK1016790A , respectively) or non‐selective (hydrogen peroxide, H 2 O 2 ) agonists. Employing human and murine cell lines expressing TRPA1 and TRPV4, and mouse primary sensory neurons from dorsal root ganglia (DRG), we observed that leonurine elicited a selective, concentration‐dependent increase in intracellular calcium levels, followed by desensitisation of both channels. Notably, TRPA1 and TRPV4 have been implicated in the development and maintenance of mechanical allodynia within models of chemotherapy‐induced peripheral neuropathy (CIPN). We used a thalidomide CIPN model to assess the efficacy of leonurine to reduce TRPA1‐ and TRPV4‐dependent mechanical allodynia. Key Results Our findings indicate that repeated, but not acute, administration of leonurine significantly reduced thalidomide‐induced mechanical allodynia, highlighting the crucial role of TRPA1 and TRPV4 desensitisation in pain modulation. Conclusions and Implications These results position leonurine as a promising candidate for pain management, warranting further investigation into long‐term therapeutic strategies and potential clinical applications.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.
- Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Section of Pharmacology and Toxicology, University of Florence, Florence, Italy.
- Department of Health Science, Forensic Toxicology Laboratory FT-LAB, University of Florence, Florence, Italy.
- Department of Information Engineering, University of Florence, Florence, Italy.
- FloNext Srl, Florence, Italy.
- Department of Agricultural, Environmental, Food and Forestry Science and Technology, University of Florence, Florence, Italy.
ORCID profiles: Romina Nassini
Funding
- Next Generation EU. National Recovery and Resilience Plan, Mission 4 Component 2 - Investment 1.4 - National Center for Gene Therapy and Drugs based on RNA Tec…
- Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP)
- A.H. Morice, University of Hull, Hull, UK
- M.J. Gunthorpe, GlaxoSmithKline, Harlow, UK
Cite
APA
Marini, M., Landini, L., Coppi, E., Tesi, M., Bellantoni, E., Chieca, M., Croce, E. B., Bonacchi, L., Brancolini, G., Bruschi, P., de Araújo, D. S. M., De Siena, G., Dimitrova, A., Mastricci, A., Rocha Mendonça, H., Scuffi, I., Venturini, M., Dos Santos Heringer, L., Vaiano, F., …, & De Logu, F. (2025). Anti‐nociceptive action of leonurine through TRPA1 and TRPV4 channels modulation. British Journal of Pharmacology. https://doi.org/10.1111/bph.70135
Vancouver
Marini M, Landini L, Coppi E, Tesi M, Bellantoni E, Chieca M, et al. Anti‐nociceptive action of leonurine through TRPA1 and TRPV4 channels modulation. British Journal of Pharmacology. 2025. doi:10.1111/bph.70135
BibTeX
@article{Marini2025,
author = {Marini, Matilde and Landini, Lorenzo and Coppi, Elisabetta and Tesi, Martina and Bellantoni, Elisa and Chieca, Martina and Croce, Emma Beatrice and Bonacchi, Lorenzo and Brancolini, Giulia and Bruschi, Piero and de Araújo, Daniel Souza Monteiro and De Siena, Gaetano and Dimitrova, Alexandra and Mastricci, Alessandra and Rocha Mendonça, Henrique and Scuffi, Irene and Venturini, Martina and Dos Santos Heringer, Luiza and Vaiano, Fabio and Nassini, Romina and De Logu, Francesco},
title = {Anti‐nociceptive action of leonurine through TRPA1 and TRPV4 channels modulation},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.70135}
}
EUVIMED